The Addition of Manual Lymph Drainage to Compression Therapy For Breast Cancer Related Lymphedema: a Randomized Controlled Trial Margaret L. McNeely Department of Rehabilitation Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada David J. Magee Faculty of Rehabilitation Medicine, Department of Physical Therapy, Cross Cancer Institute, Edmonton, Alberta, Canada Alan W. Lees Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada; Faculty of Medicine, Department of Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada Keith M. Bagnall Faculty of Medicine, Division of Anatomy, Cross Cancer Institute, Edmonton, Alberta, Canada Mark Haykowsky Faculty of Rehabilitation Medicine, Department of Physical Therapy, Cross Cancer Institute, Edmonton, Alberta, Canada John Hanson Division of Epidemiology, Cross Cancer Institute, Edmonton, Alberta, Canada Abstract Purpose. The purpose of this investigation was to compare the reduction in arm lymphedema volume achieved from manual lymph drainage massage (MLD) in combination with multi-layered compression bandaging (CB) to that achieved by CB alone. Methods and materials. Fifty women with lymphedema (mean age of 59 years ± 13 years) were randomly assigned to 4 weeks of combined MLD/CB or CB alone. The primary study endpoint was the reduction in arm lymphedema volume, which was determined by water displacement volumetry and measurement of circumference. Independent assessors, blinded to subject treatment assignment, performed the outcome measurements. Results. Arm lymphedema volume decreased significantly after 4 weeks irrespective of treatment assignment (p < 0.001). Individuals with mild lymphedema receiving combined MLD/CB had a significantly larger percentage reduction in volume compared to individuals with mild lymphedema receiving CB alone, and compared to individuals with moderate or severe lymphedema receiving either treatment. Conclusion. These findings indicate that CB, with or without MLD, is an effective intervention in reducing arm lymphedema volume. The findings suggest that CB on its own should be considered as a primary treatment option in reducing arm lymphedema volume. There may be an additional benefit from the application of MLD for women with mild lymphedema; however, this finding will need to be further examined in the research setting. Breast Cancer Research and Treatment 86 (2): 95-106, July 2004 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.